Content deleted Content added
Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.2 |
|||
Line 29:
Geritol was the subject of years of investigation starting in 1959 by the [[Federal Trade Commission]] (FTC). In 1965, the FTC ordered the makers of Geritol to disclose that Geritol would relieve symptoms of tiredness only in persons who suffer from [[iron deficiency anemia]], and that the vast majority of people who experience such symptoms do not have such a deficiency. Geritol's claims were discredited in court findings as "conduct amounted to [[gross negligence]] and bordered on recklessness," ruled as a false and misleading claim, and heavily penalized with fines totaling $812,000 (equivalent to [[$]]{{Format price|{{Inflation|US|812000|1973}}}} in {{Inflation/year|US}} dollars),{{Inflation-fn|US}} the largest FTC fine up to that date (1973).<ref name="time">{{cite magazine|url=http://www.time.com/time/magazine/article/0,9171,906840,00.html|title=Geritol's Bitter Pill|magazine=Time|date=February 5, 1973|url-status=dead|archive-url=https://web.archive.org/web/20081214084141/http://www.time.com/time/magazine/article/0,9171,906840,00.html|archive-date=December 14, 2008}}</ref><ref>{{cite court|url=https://law.resource.org/pub/us/case/reporter/F2/381/381.F2d.884.16969.html|vol=381|reporter=F.2d|opinion=884|litigants=The J. B. WILLIAMS COMPANY, Inc., and Parkson Advertising Agency, Inc., Petitioner, v. FEDERAL TRADE COMMISSION, Respondent|court=United States Court of Appeals Sixth Circuit|date=August 11, 1967}}</ref> Although subsequent trials and appeals from 1965 to 1973 concluded that some of the FTC demands exceeded its authority, Geritol was already well known and continued to be the largest U.S. company selling iron and B-vitamin supplements through 1979.
Since then, supplemental iron products, including Geritol, have been contraindicated because of concerns over [[iron overload|hemochromatosis]],<ref>[http://egov.oregon.gov/DHS/ph/cdsummary/1997/ohd4616.pdf "HEMOCHROMATOSIS: A COMMON (YET PREVENTABLE) CHRONIC DISEASE"], ''CD Summary'', Vol. 46, No. 16. August 5, 1997.</ref><ref>[http://dietary-supplements.info.nih.gov/factsheets/iron.asp''Dietary Supplement Fact Sheet: Iron''] {{Webarchive|url=https://web.archive.org/web/20090531085023/http://dietary-supplements.info.nih.gov/factsheets/iron.asp |date=2009-05-31 }}
Office of Dietary Supplements • National Institutes of Health. August 24, 2007. Retrieved May 26, 2009</ref> and serious questions raised in studies for men, postmenopausal women, and nonanemic patients with liver disease, heart disease, type 2 diabetes, or cancer.<ref>TF Emery (1991) [https://books.google.com/books?hl=en&id=jxsw4tPVUdUC&dq=hemachromatosis&printsec=frontcover&source=web&ots=ZZJxDOtVX_&sig=6ueF94lm37Zw7W07fmy27lketkA#PPA1,M1 Iron and Your Health: Facts and Fallacies],
''CRC''. {{ISBN|0-8493-6763-8}}</ref><ref>RB Lauffer (1992) [https://books.google.com/books?hl=en&id=55PJK-1EWEgC&dq=overload&printsec=frontcover&source=web&ots=Vg4VOcpiTV&sig=oxUcVHdB3AY5t-JPToNkAAaEE-E Iron and Human Disease], ''CRC''. {{ISBN|0-8493-6779-4}}</ref>
| |||